Get started
Author

Stefanie V. Junk

Observed names: Junk, Stefanie V., Junk, Stefanie Verena, S Junk, S. Junk, Stefanie Junk, Stefanie Verena Junk
Observed institutions: University of Zurich, Christian-Albrechts-Universität zu Kiel, Medizinische Hochschule Hannover, Jazz Pharmaceuticals (United States), University Hospital Schleswig-Holstein, Heinrich Heine University Düsseldorf, Charité - Universitätsmedizin Berlin
ORCID: 0000-0001-8206-9463
Observed ORCID: 0000-0001-8206-9463
OpenAlex ID: A5017206901
IKZF1 plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
2018 · Martin Stanulla, Elif Dagdan, et al. · Journal of Clinical Oncology · 303
PDF
ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies
2024 · Sarah Elitzur, Ruth Shiloh, et al. · Blood · 29
PDF
Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia
2021 · Martin Stanulla, Elke Schaeffeler, et al. · Leukemia · 26
PDF
Prognostic impact of IKZF1 deletions in association with vincristine–dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95
2017 · L Hinze, A Möricke, et al. · Leukemia · 25
PDF
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia
2023 · Chiara Palmi, Silvia Bresolin, et al. · HemaSphere · 16
Benchmarking whole exome sequencing in the German network for personalized medicine
2024 · Michael Menzel, Mihaela Martis-Thiele, et al. · European Journal of Cancer · 12
PDF
Bortezomib Treatment can Overcome Glucocorticoid Resistance in Childhood B-cell Precursor Acute Lymphoblastic Leukemia Cell Lines
2015 · S. Junk, G. Cario, et al. · Klinische Pädiatrie · 12
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group
2023 · Stefanie V. Junk, Elke Schaeffeler, et al. · Journal of Experimental & Clinical Cancer Research · 10
PDF
TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia
2019 · Stefanie V. Junk, Norman Klein, et al. · Haematologica · 9
Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia—a case-control study
2024 · Stefanie V. Junk, Alisa Förster, et al. · Leukemia · 8
PDF
Genetic Variation in ABCC4 and CFTR and Acute Pancreatitis during Treatment of Pediatric Acute Lymphoblastic Leukemia
2021 · Thies Bartram, Peter Schütte, et al. · Journal of Clinical Medicine · 7
PDF
Germline variants observed in pediatric cancer patients related to hereditary breast and ovarian cancer in adults
2025 · Katharina Daugs, Danielle Brandes, et al. · International Journal of Cancer · 5
PDF
Overt and covert genetic causes of pediatric acute lymphoblastic leukemia
2025 · Ulrik Stoltze, Stefanie V. Junk, et al. · Leukemia · 5
Hyperdiploid acute lymphoblastic leukemia in children with LZTR1 germline variants
2024 · Lisa Zipper, Rabea Wagener, et al. · HemaSphere · 3
PDF
Proteasome Inhibitor Bortezomib Induces Apoptosis in Prednisone-Resistant Childhood Acute Lymphoblastic Leukemia Cells.
2009 · Stefanie Junk, Melchior Lauten, et al. · Blood · 2
Role of common host genome variants in Childhood Acute Lymphoblastic Leukemia
2025 · Theis Mikkelsen, Marianne Helenius, et al. · Leukemia · 1
PDF
A multi-dimensional approach to recognize genetic predisposition in children with acute lymphoblastic leukemia
2025 · Stefanie V. Junk, Laura R. Bettini, et al. · EJC Paediatric Oncology · 1
PDF
Genome-Wide Association Study (GWAS) of High-Risk Minimal Residual Disease and Relapse in B-Cell Acute Lymphoblastic Leukemia on Trial AIEOP-BFM ALL 2000
2017 · Laura Hinze, Stefanie V. Junk, et al. · Blood · 1
TP53, ETV6 and RUNX1 Germline Variants in Patients Developing Secondary Neoplasms after Treatment for Childhood Acute Lymphoblastic Leukemia
2017 · Stefanie V. Junk, Norman Klein, et al. · Blood · 1
High-Hyperdiploid Acute Lymphoblastic Leukemia in Children with LZTR1 Germline Variants
2023 · Triantafyllia Brozou, Arndt Borkhardt, et al. · Blood
PDF
Ph-like and IKZF1plus Features in Children with Down Syndrome and B Cell Precursor Acute Lymphoblastic Leukemia
2022 · Chiara Palmi, Silvia Bresolin, et al. · Blood
3159 – Ph-like and Ikzf1plus Features in Children With Down Syndrome Acute Lymphoblastic Leukaemia
2022 · Chiara Palmi, Silvia Bresolin, et al. · Experimental Hematology
TP53 single nucleotide variants (SNV) in patients developing second malignant neoplasms after treatment for childhood acute lymphoblastic leukemia
2016 · S Junk, N Klein, et al. · Klinische Pädiatrie
Proteasome inhibitor bortezomib induces apoptosis in prednisone-resistant childhood acute lymphoblastic leukemia cells
2010 · S Junk, M Lauten, et al. · Klinische Pädiatrie
Proteasome inhibitor bortezomib induces apoptosis in prednisone-resistant childhood acute lymphoblastic leukemia cells
2010 · Stefanie V. Junk, Melchior Lauten, et al. · F1000Research
Works count: 29
Citation count: 476
H-index: 9
I10-index: 8
Year
Topic
Type